| A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions EP van Puijenbroek, A Bate, HGM Leufkens, M Lindquist, R Orre, ... Pharmacoepidemiology and drug safety 11 (1), 3-10, 2002 | 1204 | 2002 |
| Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry T Tomson, D Battino, E Bonizzoni, J Craig, D Lindhout, E Perucca, ... The Lancet Neurology 17 (6), 530-538, 2018 | 523 | 2018 |
| The role of data mining in pharmacovigilance M Hauben, D Madigan, CM Gerrits, L Walsh, EP Van Puijenbroek Expert opinion on drug safety 4 (5), 929-948, 2005 | 334 | 2005 |
| Use of measures of disproportionality in pharmacovigilance: three Dutch examples ACG Egberts, RHB Meyboom, EP van Puijenbroek Drug safety 25, 453-458, 2002 | 210 | 2002 |
| Guidelines for submitting adverse event reports for publication WN Kelly, FM Arellano, J Barnes, U Bergman, IR Edwards, AM Fernandez, ... Pharmacoepidemiology and drug safety 16 (5), 581-587, 2007 | 207 | 2007 |
| Dose-dependent teratogenicity of valproate in mono-and polytherapy: an observational study T Tomson, D Battino, E Bonizzoni, J Craig, D Lindhout, E Perucca, ... Neurology 85 (10), 866-872, 2015 | 192 | 2015 |
| Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions EP Van Puijenbroek, WL Diemont, K van Grootheest Drug Safety 26, 293-301, 2003 | 183 | 2003 |
| On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under‐reporting on odds ratios PGM van der Heijden, EP van Puijenbroek, S van Buuren, ... Statistics in medicine 21 (14), 2027-2044, 2002 | 164 | 2002 |
| Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998 PD Van Der Linden, EP Van Puijenbroek, J Feenstra, BA In ‘T Veld, ... Arthritis Care & Research: Official Journal of the American College of …, 2001 | 162 | 2001 |
| Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs EP van Puijenbroek, ACG Egberts, ER Heerdink, HGM Leufkens European journal of clinical pharmacology 56, 733-738, 2000 | 158 | 2000 |
| Signalling possible drug–drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole EP Van Puijenbroek, ACG Egberts, RHB Meyboom, HGM Leufkens British journal of clinical pharmacology 47 (6), 689-693, 1999 | 156 | 1999 |
| Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in The Netherlands IA Eland, EP Van Puijenbroek, M Sturkenboom, JHP Wilson, BHC Stricker The American journal of gastroenterology 94 (9), 2417-2422, 1999 | 154 | 1999 |
| Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study ST de Vries, P Denig, C Ekhart, JS Burgers, N Kleefstra, PGM Mol, ... British journal of clinical pharmacology 85 (7), 1507-1515, 2019 | 152 | 2019 |
| Contribution of pharmacists to the reporting of adverse drug reactions AC Van Grootheest, EP Van Puijenbroek, LTW de Jong–van den Berg Pharmacoepidemiology and drug safety 11 (3), 205-210, 2002 | 116 | 2002 |
| Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case–control study using spontaneous reports I Schillevoort, EP Van Puijenbroek, A de Boer, RAC Roos, PAF Jansen, ... International clinical psychopharmacology 17 (2), 75-79, 2002 | 111 | 2002 |
| Motives for reporting adverse drug reactions by patient-reporters in the Netherlands F van Hunsel, C van der Welle, A Passier, E van Puijenbroek, ... European journal of clinical pharmacology 66, 1143-1150, 2010 | 99 | 2010 |
| What future healthcare professionals need to know about pharmacovigilance: introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects R van Eekeren, L Rolfes, AS Koster, L Magro, G Parthasarathi, ... Drug safety 41, 1003-1011, 2018 | 90 | 2018 |
| Antiepileptic drugs and intrauterine death: a prospective observational study from EURAP T Tomson, D Battino, E Bonizzoni, JJ Craig, D Lindhout, E Perucca, ... Neurology 85 (7), 580-588, 2015 | 89 | 2015 |
| The reporting odds ratio versus the proportional reporting ratio:'deuce'. P Waller, E van Puijenbroek, A Egberts, S Evans Pharmacoepidemiology and drug safety 13 (8), 525-526, 2004 | 88 | 2004 |
| Adverse drug reaction reports of patients and healthcare professionals—differences in reported information L Rolfes, F van Hunsel, S Wilkes, K van Grootheest, E van Puijenbroek Pharmacoepidemiology and drug safety 24 (2), 152-158, 2015 | 86 | 2015 |
